Research Comparison

Selank vs Semax

Side-by-side research comparison of Selank and Semax across our PubMed, ClinicalTrials.gov, and EuropePMC corpus. 3 head-to-head studies plus 59 on Selank and 54 on Semax.

3 head-to-head · 59 on Selank · 54 on Semax

At a glance

  Selank Semax
Drug class nootropic, anxiolytic nootropic
Studies in corpus 59 54
Highest evidence tier rct review
Evidence tier mix other · 12 rct · 1 preclinical animal · 35 in vitro · 6 preclinical animal · 37 other · 6 review · 2 in vitro · 5
Studies with explicit sample size 8 4
Head-to-head studies in corpus 3

Lab evidence, head to head

Beyond the literature: here's what third-party Certificate-of-Analysis records (Janoshik, BCC, Auxlabs) say about real Selank and Semax batches we've tested. Aggregate, public data — cross-reference against the studies below.

Selank

We tested 1588 Selank batches across 636 manufacturers, 99.66% avg purity.

1588
Batches tested
636
Manufacturers
99.66%
Avg purity
1
Failed <90%
50
Underdosed >10%
All Selank COA records →

Semax

We tested 1731 Semax batches across 694 manufacturers, 99.44% avg purity.

1731
Batches tested
694
Manufacturers
99.44%
Avg purity
29
Underdosed >10%
All Semax COA records →

We hold deeper lab coverage on Semax (1731 batches tested). Selank edges ahead on average measured purity (99.66% vs 99.44%) — a narrow gap; weigh it against failed-batch and underdose counts above.

Head-to-head studies

Studies in our corpus that mention both Selank and Semax — the gold-standard direct comparison evidence.

Top studies per peptide

Selank (59 studies)

Semax (54 studies)

Vendor data

Looking for vendor-level purity, endotoxin, and HPLC data on Selank or Semax? TitrateLab tracks Certificate-of-Analysis records from the major peptide labs (Janoshik, BCC, Auxlabs) alongside the research above. Cross-reference vendor batches against the studies on this page.

Explore each peptide